Tina Izard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tina Izard has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Erumbi S. Rangarajan
Department of Cancer Biology, The Scripps Research Institute, Jupiter, Florida 33458, USA
6 shared publicationsS. D. Yogesha
Department of Cancer Biology, Cell Adhesion Laboratory, The Scripps Research Institute, Jupiter, Florida 33458, USA
4 shared publicationsJun Hyuck Lee
Cell Adhesion Laboratory, Department of Cancer Biology, The Scripps Research Institute, Jupiter, Florida 33458
3 shared publicationsGerard Bricogne
Global Phasing Ltd., Sheraton House, Castle Park, Cambridge CB3 0AX, England
2 shared publicationsA. Sharff
Global Phasing Ltd, Sheraton House Castle Park, Cambridge CB3 0AX, United Kingdom
1 shared publicationAndrew J. Sharff
Global Phasing Ltd. Sheraton House, Castle Park, Cambridge CB3 0AX, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 6 January 2013
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 20 (2) , 188-193
Dimer asymmetry defines α-catenin interactions
The protein α-catenin has an essential role in stabilizing cell-cell junctions, and it is involved in multiple interactions with other cytoskeleton proteins. The crystal structure of nearly full-length human α-catenin now reveals a handshake-like dimer with the two monomers in distinct conformations. This dimer asymmetry is important for F-actin binding and for interactions with activated vinculin. The F-actin–binding cytoskeletal protein α-catenin interacts with β-catenin–cadherin complexes and stabilizes cell-cell junctions. The β-catenin–α-catenin complex cannot bind F-actin, whereas interactions of α-catenin with the cytoskeletal protein vinculin appear to be necessary to stabilize adherens junctions. Here we report the crystal structure of nearly full-length human α-catenin at 3.7-Å resolution. α-catenin forms an asymmetric dimer where the four-helix bundle domains of each subunit engage in distinct intermolecular interactions. This results in a left handshake–like dimer, wherein the two subunits have remarkably different conformations. The crystal structure explains why dimeric α-catenin has a higher affinity for F-actin than does monomeric α-catenin, why the β-catenin–α-catenin complex does not bind F-actin, how activated vinculin links the cadherin–catenin complex to the cytoskeleton and why α-catenin but not inactive vinculin can bind F-actin.
- 6 January 2013
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 20 (2) , 188-193
Open AccessDimer asymmetry defines α-catenin interactions
The protein α-catenin has an essential role in stabilizing cell-cell junctions, and it is involved in multiple interactions with other cytoskeleton proteins. The crystal structure of nearly full-length human α-catenin now reveals a handshake-like dimer with the two monomers in distinct conformations. This dimer asymmetry is important for F-actin binding and for interactions with activated vinculin. The F-actin–binding cytoskeletal protein α-catenin interacts with β-catenin–cadherin complexes and stabilizes cell-cell junctions. The β-catenin–α-catenin complex cannot bind F-actin, whereas interactions of α-catenin with the cytoskeletal protein vinculin appear to be necessary to stabilize adherens junctions. Here we report the crystal structure of nearly full-length human α-catenin at 3.7-Å resolution. α-catenin forms an asymmetric dimer where the four-helix bundle domains of each subunit engage in distinct intermolecular interactions. This results in a left handshake–like dimer, wherein the two subunits have remarkably different conformations. The crystal structure explains why dimeric α-catenin has a higher affinity for F-actin than does monomeric α-catenin, why the β-catenin–α-catenin complex does not bind F-actin, how activated vinculin links the cadherin–catenin complex to the cytoskeleton and why α-catenin but not inactive vinculin can bind F-actin.
- Open Access
- 1 May 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (22) , 18492-18499
The Cytoskeletal Protein α-Catenin Unfurls upon Binding to Vinculin
- 1 May 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (22) , 18492-18499
Open AccessThe Cytoskeletal Protein α-Catenin Unfurls upon Binding to Vinculin
- Open Access
- 14 February 2012
- Published by Wiley in Protein Science
- Vol. 21 (4) , 583-588
Crystal structure of vinculin in complex with vinculin binding site 50 (VBS50), the integrin binding site 2 (IBS2) of talin
The cytoskeletal protein talin activates integrin receptors by binding of its FERM domain to the cytoplasmic tail of β‐integrin. Talin also couples integrins to the actin cytoskeleton, largely by binding to and activating the cytoskeletal protein vinculin, which binds to F‐actin through the agency of its five‐helix bundle tail (Vt) domain. Talin activates vinculin by means of buried amphipathic α‐helices coined vinculin binding sites (VBSs) that reside within numerous four‐ and five‐helix bundle domains that comprise the central talin rod, which are released from their buried locales by means of mechanical tension on the integrin:talin complex. In turn, these VBSs bind to the N‐terminal seven‐helix bundle (Vh1) domain of vinculin, creating an entirely new helix bundle that severs its head‐tail interactions. Interestingly, talin harbors a second integrin binding site coined IBS2 that consists of two five‐helix bundle domains that also contain a VBS (VBS50). Here we report the crystal structure of VBS50 in complex with vinculin at 2.3 Å resolution and show that intramolecular interactions of VBS50 within IBS2 are much more extensive versus its interactions with vinculin. Indeed, the IBS2‐vinculin interaction only occurs at physiological temperature and the affinity of VBS50 for vinculin is about 30 times less than other VBSs. The data support a model where integrin binding destabilizes IBS2 to allow it to bind to vinculin.
- 14 February 2012
- Published by Wiley in Protein Science
- Vol. 21 (4) , 583-588
Open AccessCrystal structure of vinculin in complex with vinculin binding site 50 (VBS50), the integrin binding site 2 (IBS2) of talin
The cytoskeletal protein talin activates integrin receptors by binding of its FERM domain to the cytoplasmic tail of β‐integrin. Talin also couples integrins to the actin cytoskeleton, largely by binding to and activating the cytoskeletal protein vinculin, which binds to F‐actin through the agency of its five‐helix bundle tail (Vt) domain. Talin activates vinculin by means of buried amphipathic α‐helices coined vinculin binding sites (VBSs) that reside within numerous four‐ and five‐helix bundle domains that comprise the central talin rod, which are released from their buried locales by means of mechanical tension on the integrin:talin complex. In turn, these VBSs bind to the N‐terminal seven‐helix bundle (Vh1) domain of vinculin, creating an entirely new helix bundle that severs its head‐tail interactions. Interestingly, talin harbors a second integrin binding site coined IBS2 that consists of two five‐helix bundle domains that also contain a VBS (VBS50). Here we report the crystal structure of VBS50 in complex with vinculin at 2.3 Å resolution and show that intramolecular interactions of VBS50 within IBS2 are much more extensive versus its interactions with vinculin. Indeed, the IBS2‐vinculin interaction only occurs at physiological temperature and the affinity of VBS50 for vinculin is about 30 times less than other VBSs. The data support a model where integrin binding destabilizes IBS2 to allow it to bind to vinculin.
- Open Access
- 19 October 2011
- Published by Wiley in Protein Science
- Vol. 20 (12) , 2113-2120
Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor
The merlin‐1 tumor suppressor is encoded by the Neurofibromatosis‐2 (Nf2) gene and loss‐of‐function Nf2 mutations lead to nervous system tumors in man and to several tumor types in mice. Merlin is an ERM (ezrin, radixin, moesin) family cytoskeletal protein that interacts with other ERM proteins and with components of cell–cell adherens junctions (AJs). Merlin stabilizes the links of AJs to the actin cytoskeleton. Thus, its loss destabilizes AJs, promoting cell migration and invasion, which in Nf2+/‐ mice leads to highly metastatic tumors. Paradoxically, the “closed” conformation of merlin‐1, where its N‐terminal four‐point‐one, ezrin, radixin, moesin (FERM) domain binds to its C‐terminal tail domain, directs its tumor suppressor functions. Here we report the crystal structure of the human merlin‐1 head domain when crystallized in the presence of its tail domain. Remarkably, unlike other ERM head–tail interactions, this structure suggests that binding of the tail provokes dimerization and dynamic movement and unfurling of the F2 motif of the FERM domain. We conclude the “closed” tumor suppressor conformer of merlin‐1 is in fact an “open” dimer whose functions are disabled by Nf2 mutations that disrupt this architecture.
- 19 October 2011
- Published by Wiley in Protein Science
- Vol. 20 (12) , 2113-2120
Open AccessUnfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor
The merlin‐1 tumor suppressor is encoded by the Neurofibromatosis‐2 (Nf2) gene and loss‐of‐function Nf2 mutations lead to nervous system tumors in man and to several tumor types in mice. Merlin is an ERM (ezrin, radixin, moesin) family cytoskeletal protein that interacts with other ERM proteins and with components of cell–cell adherens junctions (AJs). Merlin stabilizes the links of AJs to the actin cytoskeleton. Thus, its loss destabilizes AJs, promoting cell migration and invasion, which in Nf2+/‐ mice leads to highly metastatic tumors. Paradoxically, the “closed” conformation of merlin‐1, where its N‐terminal four‐point‐one, ezrin, radixin, moesin (FERM) domain binds to its C‐terminal tail domain, directs its tumor suppressor functions. Here we report the crystal structure of the human merlin‐1 head domain when crystallized in the presence of its tail domain. Remarkably, unlike other ERM head–tail interactions, this structure suggests that binding of the tail provokes dimerization and dynamic movement and unfurling of the F2 motif of the FERM domain. We conclude the “closed” tumor suppressor conformer of merlin‐1 is in fact an “open” dimer whose functions are disabled by Nf2 mutations that disrupt this architecture.
- Open Access
- 1 July 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (26) , 23214-23221
Novel Vinculin Binding Site of the IpaA Invasin of Shigella
- 1 July 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (26) , 23214-23221
Open AccessNovel Vinculin Binding Site of the IpaA Invasin of Shigella
- Open Access
- 6 June 2011
- Published by Wiley in Protein Science
- Vol. 20 (8) , 1471-1476
Intermolecular versus intramolecular interactions of the vinculin binding site 33 of talin
The cytoskeletal proteins talin and vinculin are localized at cell‐matrix junctions and are key regulators of cell signaling, adhesion, and migration. Talin couples integrins via its FERM domain to F‐actin and is an important regulator of integrin activation and clustering. The 220 kDa talin rod domain comprises several four‐ and five‐helix bundles that harbor amphipathic α‐helical vinculin binding sites (VBSs). In its inactive state, the hydrophobic VBS residues involved in binding to vinculin are buried within these helix bundles, and the mechanical force emanating from bound integrin receptors is thought necessary for their release and binding to vinculin. The crystal structure of a four‐helix bundle of talin that harbors one of these VBSs, coined VBS33, was recently determined. Here we report the crystal structure of VBS33 in complex with vinculin at 2 Å resolution. Notably, comparison of the apo and vinculin bound structures shows that intermolecular interactions of the VBS33 α‐helix with vinculin are more extensive than the intramolecular interactions of the VBS33 within the talin four‐helix bundle.
- 6 June 2011
- Published by Wiley in Protein Science
- Vol. 20 (8) , 1471-1476
Open AccessIntermolecular versus intramolecular interactions of the vinculin binding site 33 of talin
The cytoskeletal proteins talin and vinculin are localized at cell‐matrix junctions and are key regulators of cell signaling, adhesion, and migration. Talin couples integrins via its FERM domain to F‐actin and is an important regulator of integrin activation and clustering. The 220 kDa talin rod domain comprises several four‐ and five‐helix bundles that harbor amphipathic α‐helical vinculin binding sites (VBSs). In its inactive state, the hydrophobic VBS residues involved in binding to vinculin are buried within these helix bundles, and the mechanical force emanating from bound integrin receptors is thought necessary for their release and binding to vinculin. The crystal structure of a four‐helix bundle of talin that harbors one of these VBSs, coined VBS33, was recently determined. Here we report the crystal structure of VBS33 in complex with vinculin at 2 Å resolution. Notably, comparison of the apo and vinculin bound structures shows that intermolecular interactions of the VBS33 α‐helix with vinculin are more extensive than the intramolecular interactions of the VBS33 within the talin four‐helix bundle.
- Open Access
- 1 June 2011
- Published by Wiley in Protein Science
- Vol. 20 (8) , 1464-1470
Apo raver1 structure reveals distinct RRM domain orientations
Raver1 is a multifunctional protein that modulates both alternative splicing and focal adhesion assembly by binding to the nucleoplasmic splicing repressor polypyrimidine tract protein (PTB) or to the cytoskeletal proteins vinculin and α-actinin. The amino-terminal region of raver1 has three RNA recognition motif (RRM1, RRM2, and RRM3) domains, and RRM1 interacts with the vinculin tail (Vt) domain and vinculin mRNA. We previously determined the crystal structure of the raver1 RRM1–3 domains in complex with Vt at 2.75 Å resolution. Here, we report crystal structure of the unbound raver1 RRM1–3 domains at 2 Å resolution. The apo structure reveals that a bound sulfate ion disrupts an electrostatic interaction between the RRM1 and RRM2 domains, triggering a large relative domain movement of over 30°. Superposition with other RNA-bound RRM structures places the sulfate ion near the superposed RNA phosphate group suggesting that this is the raver1 RNA binding site. While several single and some tandem RRM domain structures have been described, to the best of our knowledge, this is the second report of a three-tandem RRM domain structure.
- 1 June 2011
- Published by Wiley in Protein Science
- Vol. 20 (8) , 1464-1470
Open AccessApo raver1 structure reveals distinct RRM domain orientations
Raver1 is a multifunctional protein that modulates both alternative splicing and focal adhesion assembly by binding to the nucleoplasmic splicing repressor polypyrimidine tract protein (PTB) or to the cytoskeletal proteins vinculin and α-actinin. The amino-terminal region of raver1 has three RNA recognition motif (RRM1, RRM2, and RRM3) domains, and RRM1 interacts with the vinculin tail (Vt) domain and vinculin mRNA. We previously determined the crystal structure of the raver1 RRM1–3 domains in complex with Vt at 2.75 Å resolution. Here, we report crystal structure of the unbound raver1 RRM1–3 domains at 2 Å resolution. The apo structure reveals that a bound sulfate ion disrupts an electrostatic interaction between the RRM1 and RRM2 domains, triggering a large relative domain movement of over 30°. Superposition with other RNA-bound RRM structures places the sulfate ion near the superposed RNA phosphate group suggesting that this is the raver1 RNA binding site. While several single and some tandem RRM domain structures have been described, to the best of our knowledge, this is the second report of a three-tandem RRM domain structure.
- 25 November 2010
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology and Crystallization Communications
- Vol. 66 (12) , 1617-1620
Improving the diffraction of full-length human selenomethionyl metavinculin crystals by streak-seeding
Metavinculin is an alternatively spliced isoform of vinculin that has a 68-residue insert in its tail domain (1134 total residues) and is exclusively expressed in cardiac and smooth muscle tissue, where it plays important roles in myocyte adhesion complexes. Mutations in the metavinculin-specific insert are associated with dilated cardiomyopathy (DCM) in man. Crystals of a DCM-associated mutant of full-length selenomethionine-labeled metavinculin grown by hanging-drop vapor diffusion diffracted poorly and were highly sensitive to radiation, preventing the collection of a complete X-ray diffraction data set at the highest possible resolution. Streak-seeding markedly improved the stability, crystal-growth rate and diffraction quality of DCM-associated mutant metavinculin crystals, allowing complete data collection to 3.9 Å resolution. These crystals belonged to space group P43212, with two molecules in the asymmetric unit and unit-cell parameters a = b = 170, c = 211 Å, = = = 90°.
- 25 November 2010
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology and Crystallization Communications
- Vol. 66 (12) , 1617-1620
Improving the diffraction of full-length human selenomethionyl metavinculin crystals by streak-seeding
Metavinculin is an alternatively spliced isoform of vinculin that has a 68-residue insert in its tail domain (1134 total residues) and is exclusively expressed in cardiac and smooth muscle tissue, where it plays important roles in myocyte adhesion complexes. Mutations in the metavinculin-specific insert are associated with dilated cardiomyopathy (DCM) in man. Crystals of a DCM-associated mutant of full-length selenomethionine-labeled metavinculin grown by hanging-drop vapor diffusion diffracted poorly and were highly sensitive to radiation, preventing the collection of a complete X-ray diffraction data set at the highest possible resolution. Streak-seeding markedly improved the stability, crystal-growth rate and diffraction quality of DCM-associated mutant metavinculin crystals, allowing complete data collection to 3.9 Å resolution. These crystals belonged to space group P43212, with two molecules in the asymmetric unit and unit-cell parameters a = b = 170, c = 211 Å, = = = 90°.
- Open Access
- 19 May 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (5) , e10679
A Helix Replacement Mechanism Directs Metavinculin Functions
Cells require distinct adhesion complexes to form contacts with their neighbors or the extracellular matrix, and vinculin links these complexes to the actin cytoskeleton. Metavinculin, an isoform of vinculin that harbors a unique 68-residue insert in its tail domain, has distinct actin bundling and oligomerization properties and plays essential roles in muscle development and homeostasis. Moreover, patients with sporadic or familial mutations in the metavinculin-specific insert invariably develop fatal cardiomyopathies. Here we report the high resolution crystal structure of the metavinculin tail domain, as well as the crystal structures of full-length human native metavinculin (1,134 residues) and of the full-length cardiomyopathy-associated ΔLeu954 metavinculin deletion mutant. These structures reveal that an α-helix (H1′) and extended coil of the metavinculin insert replace α-helix H1 and its preceding extended coil found in the N-terminal region of the vinculin tail domain to form a new five-helix bundle tail domain. Further, biochemical analyses demonstrate that this helix replacement directs the distinct actin bundling and oligomerization properties of metavinculin. Finally, the cardiomyopathy associated ΔLeu954 and Arg975Trp metavinculin mutants reside on the replaced extended coil and the H1′ α-helix, respectively. Thus, a helix replacement mechanism directs metavinculin's unique functions.
- 19 May 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (5) , e10679
Open AccessA Helix Replacement Mechanism Directs Metavinculin Functions
Cells require distinct adhesion complexes to form contacts with their neighbors or the extracellular matrix, and vinculin links these complexes to the actin cytoskeleton. Metavinculin, an isoform of vinculin that harbors a unique 68-residue insert in its tail domain, has distinct actin bundling and oligomerization properties and plays essential roles in muscle development and homeostasis. Moreover, patients with sporadic or familial mutations in the metavinculin-specific insert invariably develop fatal cardiomyopathies. Here we report the high resolution crystal structure of the metavinculin tail domain, as well as the crystal structures of full-length human native metavinculin (1,134 residues) and of the full-length cardiomyopathy-associated ΔLeu954 metavinculin deletion mutant. These structures reveal that an α-helix (H1′) and extended coil of the metavinculin insert replace α-helix H1 and its preceding extended coil found in the N-terminal region of the vinculin tail domain to form a new five-helix bundle tail domain. Further, biochemical analyses demonstrate that this helix replacement directs the distinct actin bundling and oligomerization properties of metavinculin. Finally, the cardiomyopathy associated ΔLeu954 and Arg975Trp metavinculin mutants reside on the replaced extended coil and the H1′ α-helix, respectively. Thus, a helix replacement mechanism directs metavinculin's unique functions.